Cargando…

SEOM clinical guidelines in gestational trophoblastic disease (2017)

Gestational trophoblastic disease (GTD) is a rare but curable disease. Recent improvements in diagnosis and molecular biology have resulted in changes in staging and treatment. These guidelines provide evidence-based recommendation on how to manage GTD.

Detalles Bibliográficos
Autores principales: Santaballa, A., García, Y., Herrero, A., Laínez, N., Fuentes, J., De Juan, A., Rodriguez Freixinós, V., Aparicio, J., Casado, A., García-Martinez, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785593/
https://www.ncbi.nlm.nih.gov/pubmed/29149431
http://dx.doi.org/10.1007/s12094-017-1793-0
_version_ 1783295628984451072
author Santaballa, A.
García, Y.
Herrero, A.
Laínez, N.
Fuentes, J.
De Juan, A.
Rodriguez Freixinós, V.
Aparicio, J.
Casado, A.
García-Martinez, E.
author_facet Santaballa, A.
García, Y.
Herrero, A.
Laínez, N.
Fuentes, J.
De Juan, A.
Rodriguez Freixinós, V.
Aparicio, J.
Casado, A.
García-Martinez, E.
author_sort Santaballa, A.
collection PubMed
description Gestational trophoblastic disease (GTD) is a rare but curable disease. Recent improvements in diagnosis and molecular biology have resulted in changes in staging and treatment. These guidelines provide evidence-based recommendation on how to manage GTD.
format Online
Article
Text
id pubmed-5785593
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-57855932018-02-01 SEOM clinical guidelines in gestational trophoblastic disease (2017) Santaballa, A. García, Y. Herrero, A. Laínez, N. Fuentes, J. De Juan, A. Rodriguez Freixinós, V. Aparicio, J. Casado, A. García-Martinez, E. Clin Transl Oncol Clinical Guides in Oncology Gestational trophoblastic disease (GTD) is a rare but curable disease. Recent improvements in diagnosis and molecular biology have resulted in changes in staging and treatment. These guidelines provide evidence-based recommendation on how to manage GTD. Springer International Publishing 2017-11-17 2018 /pmc/articles/PMC5785593/ /pubmed/29149431 http://dx.doi.org/10.1007/s12094-017-1793-0 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Clinical Guides in Oncology
Santaballa, A.
García, Y.
Herrero, A.
Laínez, N.
Fuentes, J.
De Juan, A.
Rodriguez Freixinós, V.
Aparicio, J.
Casado, A.
García-Martinez, E.
SEOM clinical guidelines in gestational trophoblastic disease (2017)
title SEOM clinical guidelines in gestational trophoblastic disease (2017)
title_full SEOM clinical guidelines in gestational trophoblastic disease (2017)
title_fullStr SEOM clinical guidelines in gestational trophoblastic disease (2017)
title_full_unstemmed SEOM clinical guidelines in gestational trophoblastic disease (2017)
title_short SEOM clinical guidelines in gestational trophoblastic disease (2017)
title_sort seom clinical guidelines in gestational trophoblastic disease (2017)
topic Clinical Guides in Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785593/
https://www.ncbi.nlm.nih.gov/pubmed/29149431
http://dx.doi.org/10.1007/s12094-017-1793-0
work_keys_str_mv AT santaballaa seomclinicalguidelinesingestationaltrophoblasticdisease2017
AT garciay seomclinicalguidelinesingestationaltrophoblasticdisease2017
AT herreroa seomclinicalguidelinesingestationaltrophoblasticdisease2017
AT lainezn seomclinicalguidelinesingestationaltrophoblasticdisease2017
AT fuentesj seomclinicalguidelinesingestationaltrophoblasticdisease2017
AT dejuana seomclinicalguidelinesingestationaltrophoblasticdisease2017
AT rodriguezfreixinosv seomclinicalguidelinesingestationaltrophoblasticdisease2017
AT aparicioj seomclinicalguidelinesingestationaltrophoblasticdisease2017
AT casadoa seomclinicalguidelinesingestationaltrophoblasticdisease2017
AT garciamartineze seomclinicalguidelinesingestationaltrophoblasticdisease2017